← Back to headlines
Excalipoint Debuts with $68.7 Million Funding for TCE Pipeline
Excalipoint, a new company, has launched with $68.7 million in funding aimed at advancing its T-cell engager (TCE) pipeline.
18 Mar, 17:45 — 18 Mar, 17:45
Sources
Showing 1 of 1 sources
